Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) EPS (Basic): 2015-2024

Historic EPS (Basic) for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to -$3.63.

  • Insight Molecular Diagnostics' EPS (Basic) rose 65.31% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.90, marking a year-over-year increase of 34.53%. This contributed to the annual value of -$3.63 for FY2024, which is 925.17% down from last year.
  • Insight Molecular Diagnostics' EPS (Basic) amounted to -$3.63 in FY2024, which was down 925.17% from -$0.35 recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' EPS (Basic) ranged from a high of -$0.35 in FY2023 and a low of -$3.63 during FY2024.
  • In the last 3 years, Insight Molecular Diagnostics' EPS (Basic) had a median value of -$0.66 in 2022 and averaged -$1.55.
  • Per our database at Business Quant, Insight Molecular Diagnostics' EPS (Basic) soared by 46.41% in 2023 and then tumbled by 925.17% in 2024.
  • Yearly analysis of 5 years shows Insight Molecular Diagnostics' EPS (Basic) stood at -$0.46 in 2020, then slumped by 56.52% to -$0.72 in 2021, then rose by 8.33% to -$0.66 in 2022, then skyrocketed by 46.41% to -$0.35 in 2023, then crashed by 925.17% to -$3.63 in 2024.